Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.

Benzer Materyaller

• Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model.
  Yazar:: Kang, S L, ve diğerleri
  Baskı/Yayın Bilgisi: (1995)
• Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
  Yazar:: Rybak, M J, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• Pharmacodynamics of Cefepime Alone and in Combination with Various Antimicrobials against Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Infection Model
  Yazar:: Huang, Vanthida, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Activities of LY333328 and Vancomycin Administered Alone or in Combination with Gentamicin against Three Strains of Vancomycin-Intermediate Staphylococcus aureus in an In Vitro Pharmacodynamic Infection Model
  Yazar:: Aeschlimann, Jeffrey R., ve diğerleri
  Baskı/Yayın Bilgisi: (2000)
• Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.
  Yazar:: Palmer, S M, ve diğerleri
  Baskı/Yayın Bilgisi: (1996)